SER
Serina Therapeutics, Inc.
$2.00
-0.17 (-7.83%)
At close · Jul 8
Market Cap
$30.00M
Shares
14,997,505
Earnings calls and other investor events (conferences, investor days) grouped as single events — the transcript and audio, plus, for earnings calls, the 8-K earnings release and the quarter's 10-Q or 10-K, with the reported result and management tone at a glance.
Revenue & result across quarters
Revenue ($B) YoY up YoY down artefacts
LATEST
·
'25 Q4
26-03-25
▼100%
'25 Q3
25-11-13
▲154.9%
'25 Q2
25-08-11
▼100%
'25 Q1
25-05-08
▼100.5%
'24 Q4
25-03-24
▼51.7%
'24 Q3
24-11-12
▲628.6%
'24 Q2
24-08-09
▼83.3%
'24 Q1
24-05-14
▲38487.5%
'23 Q4
24-03-22
▲222.2%
'23 Q3
23-11-14
▼41.7%
'23 Q2
23-08-14
▲500%
'23 Q1
23-05-12
▼70.4%
'22 Q4
23-03-31
▼62.5%
'22 Q3
22-11-10
▼67.6%
'22 Q2
22-08-12
Earnings call
FY26 · Q1
2026-05-14
Serina Therapeutics, Inc. Q1 FY2026 Earnings Call
Diluted EPS
$-0.58
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-03-25
Serina Therapeutics, Inc. Q4 FY2025 Earnings Call
Revenue
$*
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-13
Serina Therapeutics, Inc. Q3 FY2025 Earnings Call
Revenue
$
▼ 100% YoY Diluted EPS
$-0.45
▼ 446.2% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-11
Serina Therapeutics, Inc. Q2 FY2025 Earnings Call
Revenue
$130,000
▲ 154.9% YoY Diluted EPS
$-0.66
▼ 229.4% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-08
Serina Therapeutics, Inc. Q1 FY2025 Earnings Call
Revenue
$
▼ 100% YoY Diluted EPS
$-0.49
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-03-24
Serina Therapeutics, Inc. Q4 FY2024 Earnings Call
Revenue
$*
▼ 100.5% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-12
Serina Therapeutics, Inc. Q3 FY2024 Earnings Call
Revenue
$14,000
▼ 51.7% YoY Diluted EPS
$0.13
▼ 43.5% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-09
Serina Therapeutics, Inc. Q2 FY2024 Earnings Call
Revenue
$51,000
▲ 628.6% YoY Diluted EPS
$0.51
▲ 363.6% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-14
Serina Therapeutics, Inc. Q1 FY2024 Earnings Call
Revenue
$5,000
▼ 83.3% YoY Diluted EPS
$-5.38
▼ 2790% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-03-22
Serina Therapeutics, Inc. Q4 FY2023 Earnings Call
Revenue
$3.09M*
▲ 38487.5% YoY Gross margin
1.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-14
Serina Therapeutics, Inc. Q3 FY2023 Earnings Call
Revenue
$29,000
▲ 222.2% YoY Diluted EPS
$0.23
Gross margin
117.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-14
Serina Therapeutics, Inc. Q2 FY2023 Earnings Call
Revenue
$7,000
▼ 41.7% YoY Diluted EPS
$0.11
Gross margin
57.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-12
Serina Therapeutics, Inc. Q1 FY2023 Earnings Call
Revenue
$30,000
▲ 500% YoY Diluted EPS
$0.20
Gross margin
30.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-03-31
Serina Therapeutics, Inc. Q4 FY2022 Earnings Call
Revenue
$8,000*
▼ 70.4% YoY Gross margin
87.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-10
Serina Therapeutics, Inc. Q3 FY2022 Earnings Call
Revenue
$9,000
▼ 62.5% YoY Diluted EPS
$-2.14
Gross margin
44.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-12
Serina Therapeutics, Inc. Q2 FY2022 Earnings Call
Revenue
$12,000
▼ 67.6% YoY Diluted EPS
$-2.50
Gross margin
50.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-13
Serina Therapeutics, Inc. Q1 FY2022 Earnings Call
Revenue
$5,000
▼ 91.1% YoY Gross margin
80.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-03-29
Serina Therapeutics, Inc. Q4 FY2021 Earnings Call
Revenue
$27,000*
▼ 82.9% YoY Gross margin
96.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-12
Serina Therapeutics, Inc. Q3 FY2021 Earnings Call
Revenue
$24,000
▼ 65.2% YoY Gross margin
91.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-13
Serina Therapeutics, Inc. Q2 FY2021 Earnings Call
Revenue
$37,000
▼ 17.8% YoY Gross margin
64.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-17
Serina Therapeutics, Inc. Q1 FY2021 Earnings Call
Revenue
$56,000
▼ 37.1% YoY Gross margin
94.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-03-31
Serina Therapeutics, Inc. Q4 FY2020 Earnings Call
Revenue
$158,000*
▼ 71.2% YoY Gross margin
96.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-11-16
Serina Therapeutics, Inc. Q3 FY2020 Earnings Call
Revenue
$69,000
▼ 83.2% YoY Gross margin
75.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-08-14
Serina Therapeutics, Inc. Q2 FY2020 Earnings Call
Revenue
$45,000
▼ 88.2% YoY Gross margin
93.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-05-14
Serina Therapeutics, Inc. Q1 FY2020 Earnings Call
Revenue
$89,000
▼ 77.1% YoY Gross margin
98.9%
Rev · 7q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-03-31
Serina Therapeutics, Inc. Q4 FY2019 Earnings Call
Revenue
$549,000*
▲ 75.4% YoY Gross margin
85.6%
Rev · 6q
Audio
Transcript
Slides
8-K10-K
Showing 1–26 of 26 earnings calls